Comparison of sequential intravenous/oral ciprofloxacin plus metronidazole with intravenous ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections

Surgical Infections

Volumn 7, Issue 4, 2006, Pages 341-354

  Wacha, Hannes ^a   Warren, Brian ^b   Bassaris, Harry ^c   Nikolaidis, Paul ^d   Vestweber, Karl ^e   Pichlmayr, Rudolf ^f   Engemann, Rainer ^g   Buchholz, Wolfgang ^h   Buhr, Heinz ⁱ   Von Feldmann, Frank ^j   Hohenberger, Werner ^k   Meister, Richard ^l   Cugnenc, Jacques ^m   Huten, Noël ⁿ   Chevallier, Jean Marc ^o   Letoublon, Christian ^p   Domergue, Jacques ^q   Brimas, Gintautas ^r   Pavalkis, Daninius ^s   Drews, Michael ^t   Büchler, Markus ^u   Igra, Yardena ^v   Kitzes, Ruth ^w   Lang, Ruth ^x   Solomon, Michael ^y   Smith, Ross ^z   Raz, Raul ^aa   Pfeffermann, Reuven ^ab   Dan, Michael ^ac   Senninger, Norbert ^ad   Jauch, Karl ^ae   Gebhardt, Christoph ^af   more..

^a GOETHE UNIVERSITY   (Germany)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^d AHEPA UNIVERSITY HOSPITAL   (Greece)

^e KLINIKUM LEVERKUSEN   (Germany)

^f LEIBNIZ UNIVERSITY HANNOVER   (Germany)

^g Aschaffenburg Hospital   (Germany)

^h Hospital Berlin Kaulsdorf   (Germany)

ⁱ CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^j St Joseph Hospital   (Germany)

^k UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^l Sozialstiftung Bamberg   (Germany)

^m Hopital Laennec   (France)

ⁿ SERVICE DE DERMATOLOGIE   (France)

^o Hopital Boucicaut   (France)

^p GRENOBLE UNIVERSITY HOSPITAL   (France)

^q HÔPITAL SAINT ELOI   (France)

^r VILNIUS UNIVERSITY   (Lithuania)

^s KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

^t ENT Department   (Poland)

^u UNIVERSITY OF BERN   (Switzerland)

^v TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^w CARMEL MEDICAL CENTER   (Israel)

^x MEIR MEDICAL CENTER   (Israel)

^y ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^z NEPEAN HOSPITAL   (Australia)

^aa HAEMEK MEDICAL CENTER   (Israel)

^ab KAPLAN MEDICAL CENTER   (Israel)

^ac WOLFSON MEDICAL CENTER   (Israel)

^ad UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^ae UNIVERSITY OF REGENSBURG   (Germany)

^af Nuremberg Hospital   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; CIPROFLOXACIN; METRONIDAZOLE; PLACEBO; ANTIINFECTIVE AGENT;

ABDOMINAL INFECTION; ABSCESS; ADULT; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE SEQUENCE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ERADICATION THERAPY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INFECTION COMPLICATION; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SURGICAL INFECTION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; ABDOMEN; ABDOMINAL ABSCESS; BACTERIAL INFECTION; DIGESTIVE SYSTEM DISEASE; DRUG COMBINATION; INTRAVENOUS DRUG ADMINISTRATION; MICROBIOLOGY; MIDDLE AGED; ORAL DRUG ADMINISTRATION;

ABDOMEN; ABDOMINAL ABSCESS; ADMINISTRATION, ORAL; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CIPROFLOXACIN; DIGESTIVE SYSTEM DISEASES; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; METRONIDAZOLE; MIDDLE AGED;

EID: 33947694701     PISSN: 10962964     EISSN: None     Source Type: Journal    
DOI: 10.1089/sur.2006.7.341     Document Type: Article

References (20)

1. Privitera G, Auxilia F, Ortisi G, et al. Infections in the surgical setting: Epidemiology and effect of treatment with cefotaxime in a multicenter trial including 3,032 patients. Am J Surg 1992;164:6-11.
2. Nyström PO, Bax R, Dellinger EP, et al. Proposed definitions for diagnosis, severity scoring, stratification, and outcome for trials on intra-abdominal infection. World J Surg 1990;14:148-158.
3. Bohnen JM, Solomkin JS, Dellinger EP, et al. Guidelines for clinical care: Anti-infective agents for intraabdominal infection. A Surgical Infection Society policy statement. Arch Surg 1991;127:83-89.
4. Nichols RL. Intraabdominal infections: An overview. Rev Infect Dis 1985;7:709-715.
5. Dellinger EP. Intra-abdominal infections: Treatment considerations. Infect Dis Clin Pract 1995;4:163-169.
6. Brook I. Indigenous microbial flora of humans. In Howard R, Simmons RL, eds. Surgical Infectious Diseases. Norwalk, CT: Appleton & Lange, 1995: 37-46.
7. Solomkin JS, Dellinger EP, Bohnen JM, et al. The role of oral antimicrobials for the management of intra-abdominal infections. New Horiz 1998;6:S46-S52.
8. Tyburski JG, Wilson RF, Warsow KM, et al. A trial of ciprofloxacin and metronidazole vs gentamicin and metronidazole for penetrating abdominal trauma. Arch Surg 1998;133:1289-1296.
9. Cohn SM, Lipsett PA, Buchman TG, et al. Comparison of intravenous/oral ciprofloxacin plus metronidazole versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections. Ann Surg 2000;232:254-262.
10. Solomkin JS, Reinhart HH, Dellinger EP, et al. Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections. Ann Surg 1996;223:303-315.
11. Sanders WE Jr. Efficacy, safety, and potential economic benefits of oral ciprofloxacin in the treatment of infections. Rev Infect Dis 1988;10:528-543.
12. Andersen G, Boldiston C, Woods S, et al. A cost-effectiveness evaluation of 3 antimicrobial regimens for the prevention of infective complications after abdominal surgery. Arch Surg 1996;131:744-748.
13. Goldstein EJ, Citron DM. Comparative activity of the quinolones against anaerobic bacteria isolated at community hospitals. Antimicrob Agents Chemother 1985;27:657-659.
14. Solomkin JS, Hemsell DL, Sweet R, et al. General guidelines for the evaluation of new anti-infective drugs for the treatment of intra-abdominal infections. In Beam TR Jr, Gilbert DB, Kunin CM, eds. European Guidelines for the Clinical Evaluation of Anti-Infective Drug Products. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) 1993:59-69.
15. Gart JJ. The comparison of proportions: A review of significance tests, confidence intervals and adjustments for stratification. Rev Int Statist Inst 1971;39:148-169.
16. Solomkin JS, Meakins JL, Allo MD, et al. Antibiotic trials in intra-abdominal infections: A critical evaluation of study design and outcome reporting. Ann Surg 1984;200:29-39.
17. de Marie S, vandenBergh MF, Buijk SL, et al. Bioavailability or ciprofloxacin after multiple enteral and intravenous doses in ICU patients with severe gram negative intra-abdominal infections. Intensive Care Med 1998;24:343-346.
18. Solomkin JS, Dellinger EP, Christou NV, et al. Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections. Ann Surg 1990;212:581-591.
19. Wacha H, Hau T, Dittmer R, et al. Risk factors in intraabdominal infections: A prospective multicenter study. Langenbecks Arch Surg 1999;384:24-32.
20. Nagy E, Foeldes J. Inaktivierung von Metronidazol durch Enterococcus faecalis. J Antimicrobial Chemother 1991;27:63-70.